Affimed N.V. (AFMD) Financials

AFMD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 127.5 million 46.6 million
2023-06-30 146.5 million 38.9 million
2023-03-31 183.1 million 46.7 million
2022-12-31 215.2 million 51.1 million

AFMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -22.7 million 2.0 million
2023-06-30 -36.2 million 3.5 million
2023-03-31 -36.2 million 4.5 million
2022-12-31 -33.7 million 4.6 million

AFMD Net Income

No data available :(

AFMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 103.2 million - 8.0 million
2023-06-30 130.5 million - 351209
2023-03-31 - - 488323
2022-12-31 204.2 million - 613854

AFMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 158.1 million
2023-06-30 162.4 million
2023-03-31 162.8 million
2022-12-31 152.8 million

AFMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.4 million 22.8 million 5.7 million -
2023-06-30 3262 27.5 million 6.8 million -
2023-03-31 8720 32.2 million 7.5 million -
2022-12-31 432488 35.9 million 9.2 million -

AFMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.1 million -
2023-06-30 1.5 million -
2023-03-31 4.9 million -
2022-12-31 12.0 million -

AFMD

Price: $5.38

52 week price:
2.24
11.10

Earnings Per Share: -8.56 USD

P/E Ratio: -0.62

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.5 million

Ebitda: -9.1 million

Market Capitalization: 93.6 million

Links: